We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.58%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.77B
AUM Growth
-$242M
(-8%)
Cap. Flow
-$349M
Cap. Flow
% of AUM
-12.6%
Top 10 Holdings %
Top 10 Hldgs %
18.23%
Holding
319
New
33
Increased
50
Reduced
134
Closed
77
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$30.5M |
| 2 |
AdaptHealth
AHCO
|
+$26.6M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$19.6M |
| 4 |
BJ's Restaurants
BJRI
|
+$17.7M |
| 5 |
SI
Silvergate Capital Corporation
SI
|
+$16.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MNTV
Momentive Global Inc. Common Stock
MNTV
|
+$35.4M |
| 2 |
New Fortress Energy
NFE
|
+$28.3M |
| 3 |
Immunovant
IMVT
|
+$27.9M |
| 4 |
Karyopharm Therapeutics
KPTI
|
+$25M |
| 5 |
Taylor Morrison
TMHC
|
+$23.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.04% |
| 2 | Technology | 19.82% |
| 3 | Consumer Discretionary | 16.91% |
| 4 | Industrials | 13.94% |
| 5 | Financials | 11.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Adobe
ADBE
$89.5B
| $472K | 0.02% |
992
| – | – |
|
202
Steris
STE
$20.9B
| $465K | 0.02% |
2,443
-90
| -4% | -$16.7K |
|
203
Chewy
CHWY
$8.54B
| $445K | 0.02% |
5,251
-230
| -4% | -$22.4K |
|
204
TETRA Technologies
TTI
$1.23B
| $440K | 0.02% |
+183,385
| New | +$395K |
|
205
Etsy
ETSY
$7.65B
| $425K | 0.02% |
+2,109
| New | +$441K |
|
|
SPLK
206
DELISTED
Splunk Inc
SPLK
| $422K | 0.02% |
3,113
-110
| -3% | -$17.2K |
|
207
Take-Two Interactive
TTWO
$43B
| $421K | 0.02% |
2,385
-90
| -4% | -$17.1K |
|
208
L3Harris
LHX
$55.9B
| $419K | 0.02% |
2,066
-5,467
| -73% | -$1.03M |
|
209
Citizens & Northern Corp
CZNC
$436M
| $408K | 0.01% |
17,150
+6,790
| +66% | +$147K |
|
210
ServiceNow
NOW
$102B
| $406K | 0.01% |
4,060
| – | – |
|
211
Lumentum
LITE
$59.4B
| $401K | 0.01% |
4,391
-1,140
| -21% | -$106K |
|
212
Spotify
SPOT
$99.2B
| $386K | 0.01% |
1,442
-50
| -3% | -$15.6K |
|
213
MongoDB
MDB
$24B
| $373K | 0.01% |
1,394
-787
| -36% | -$279K |
|
214
Meridian
MRBK
$236M
| $355K | 0.01% |
27,318
-4,940
| -15% | -$58.1K |
|
|
XONE
215
DELISTED
The ExOne Company
XONE
| $354K | 0.01% |
11,300
| – | – |
|
216
Trade Desk
TTD
$8.13B
| $340K | 0.01% |
5,220
-100
| -2% | -$7.73K |
|
|
CTLP
217
DELISTED
Cantaloupe
CTLP
| $338K | 0.01% |
28,830
-1,050,012
| -97% | -$11.1M |
|
218
Matthews International
MATW
$864M
| $327K | 0.01% |
8,270
| – | – |
|
219
Mine Safety
MSA
$6.74B
| $317K | 0.01% |
2,110
| – | – |
|
|
AQUA
220
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $313K | 0.01% |
11,900
+7,140
| +150% | +$190K |
|
|
EXAS
221
DELISTED
Exact Sciences
EXAS
| $294K | 0.01% |
2,233
-80
| -3% | -$11K |
|
222
American Superconductor
AMSC
$1.48B
| $286K | 0.01% |
15,084
-10,864
| -42% | -$269K |
|
223
Maravai LifeSciences
MRVI
$997M
| $275K | 0.01% |
7,730
-17,926
| -70% | -$594K |
|
224
Enterprise Financial Services Corp
EFSC
$2.41B
| $271K | 0.01% |
+5,480
| New | +$231K |
|
225
West Pharmaceutical
WST
$23.1B
| $262K | 0.01% |
930
| – | – |
|
Similar funds
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
FAM
Emerald Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, Emerald Advisers held 319 positions worth $2.77B, down 8% from $3.01B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Advisers withdrew a net $349M in Q1 2021, closing 77 positions and reducing 134 holdings. Its most notable exit was Momentive Global Inc. Common Stock, an estimated $35.4M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Emerald Advisers opened a new position in Reata Pharmaceuticals, Inc. Class A Common Stock worth $26.1M.
- Emerald Advisers's largest Q1 2021 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 261,467 shares worth $26.1M.
- Emerald Advisers added most to AdaptHealth in Q1 2021, an estimated $26.6M increase.
- Emerald Advisers's biggest Q1 2021 reduction was New Fortress Energy, cutting an estimated $28.3M.
- Emerald Advisers fully exited Momentive Global Inc. Common Stock in Q1 2021, selling an estimated $35.4M.
- Emerald Advisers's ten largest holdings make up 18% of its $2.77B portfolio in Q1 2021.
- Emerald Advisers opened 33 new positions and closed 77 in Q1 2021.
- Emerald Advisers's portfolio value fell 8% quarter-over-quarter to $2.77B.
Based on Emerald Advisers's 13F filing for Q1 2021, filed 29 Apr 2021.